Biotech Stocks

CTI BioPharma Reiterated With A Buy At H.C. Wainwright

In a research note issued this morning, H.C.

We Continue To Remain Supportive Of Vertex Shares, Says Janney Analyst

In a research note released this morning, Janney Montgomery Scott reiterated coverage on Vertex Pharmaceuticals (VRTX) with an Outperform rating and $90 fair value estimate. A data …

We Like Ariad’s Story But See Limited Newsflow, Says UBS’ Andrew Peters

Ariad Pharmaceuticals (ARIA) had its price target reduced by UBS from $7.50 to $7.

TG Therapeutics Is Poised For Upside, Says Roth Capital Analyst

In a research note released today, Roth Capital reiterated coverage on TG Therapeutics, Inc. (TGTX) with a Buy rating and a price target of $15.

Regeneron Has Solid Growth Prospects, Says Roth Capital Analyst

In a research note released this morning, Roth Capital reiterated coverage on Regeneron Pharmaceuticals (REGN) with a Buy rating and a price target of $382.00, following the announcement that …

Palatin Technologies Reiterated With A Buy At Roth Capital

In a research note issued this morning, Roth Capital reiterated coverage with a “Buy” rating on Palatin Technologies, Inc. (PTN) and a price target of $6.

Roth Capital Reiterates Buy Rating for Celator Pharmaceuticals

In a research note released this morning, Roth Capital reiterated coverage on Celator Pharmaceuticals, Inc (CPXX) with an Outperform rating and a price target of $15.00, which is based …

William Blair Maintains Outperform On BioDelivery Sciences

William Blair today maintained an Outperform rating on BioDelivery Sciences (BDSI) with $23.00 price target, which is derived through a net present value analysis …

William Blair Reiterates Outperform Rating For Dynavax

In a research note released this morning, William Blair reiterated coverage on Dynavax Technologies Corporation (DVAX) with an Outperform rating and a price target of …

OraSure Technologies Price Target Raised at Canaccord Following Agreement With AbbVie

In a research note issued today, Canaccord analyst Mark Massaro reiterated a Buy rating and boosted his price target on OraSure Technologies (OSUR) to $11.00 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts